InnoMedica's innovative drug delivery system allows for the selective transport of active pharmaceutical agents to the affected area, resulting in more effective treatment of diseases such as cancer with minimal side effects. Their nanotechnology-based approach utilizes nanocarriers that circulate in the bloodstream for longer periods of time and are released with precision at the designated location in the body. This technology has the potential to revolutionize the way tumor diseases are treated, enabling the development of novel therapeutics that could significantly improve patient outcomes.